Scott Kellen is Secretary at DiaMedica Therapeutics Inc. (DMAC). They have made 8 open-market trades across 2 companies since 2013, most recently 2023-06-23.
CIK 0001490476
8 open-market purchases totalling $119K since 2013, never a sale. Across 6 scored buys the stock is up 20.4% at ninety days, and 15.5 points ahead of the S&P over the same stretch.
6 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 67% | 50% |
| Avg Move | -1.2% | +19.3% | +20.4% |
| Alpha | -0.3% | +17.0% | +15.5% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DMAC | BUY | 2023-06-23 | 2023-06-26 | $3.91 | $39K | -11.1% | -25.1% | -42.1% |
| DMAC | BUY | 2021-08-16 | 2021-08-16 | $3.15 | $32K | +15.3% | +13.8% | +18.5% |
| DMAC | BUY | 2020-11-09 | 2020-11-10 | $4.19 | $8K | -1.4% | +59.1% | +120.7% |
| DMAC | BUY | 2019-08-19 | 2019-08-19 | $2.43 | $7K | +15.2% | +10.0% | +50.0% |
| DMAC | BUY | 2019-05-24 | 2019-05-28 | $2.94 | $12K | +1.7% | +60.7% | -13.8% |
| DMAC | BUY | 2018-12-11 | 2018-12-11 | $4.00 | $5K | -26.7% | -2.7% | -11.2% |
| KIPS | BUY | 2013-08-30 | 2013-09-03 | $0.78 | $8K | N/A | N/A | N/A |
| KIPS | BUY | 2013-08-12 | 2013-08-12 | $0.82 | $8K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.